MMAE, the cytotoxic payload of EV, is also recognized as a substrate for ABC transporters,14 suggesting that upregulation of these transporters could similarly diminish the efficacy of EV by actively removing the drug from tumour cells. The gene discussed is ABCG2; the disease is neoplasm.